Meghan E Munger
Overview
Explore the profile of Meghan E Munger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
666
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Boyer E, Stout J, Laine J, Gutknecht S, Araujo de Oliveira L, Munger M, et al.
J Bone Joint Surg Am
. 2018 Jan;
100(1):31-41.
PMID: 29298258
Background: We examined long-term outcomes across the domains of the International Classification of Functioning, Disability and Health for 2 groups of participants with cerebral palsy who demonstrated crouch gait at...
12.
Boyer E, Stout J, Laine J, Gutknecht S, Oliveira L, Munger M, et al.
Gait Posture
. 2017 Sep;
58:527-532.
PMID: 28961550
A distal femoral extension osteotomy with patellar tendon advancement (DFEO+PTA) is a common treatment for individuals with cerebral palsy (CP) who walk in crouch. Musculoskeletal modeling suggests that the typical...
13.
Munger M, Aldahondo N, Krach L, Novacheck T, Schwartz M
Dev Med Child Neurol
. 2017 Aug;
59(11):1196-1203.
PMID: 28786493
Aim: To examine long-term outcomes of selective dorsal rhizotomy (SDR) 10 to 17 years after surgery. Method: Participants who underwent SDR had spastic diplegic cerebral palsy (CP), completed baseline gait...
14.
Gutknecht S, Schwartz M, Munger M
Dev Med Child Neurol
. 2015 Apr;
57(11):1070-5.
PMID: 25914153
Aim: The aim of this study was to retrospectively analyze changes in age- and sex-adjusted body mass index (BMI) in ambulatory children with cerebral palsy (CP) who underwent selective dorsal...
15.
Zhou Q, Munger M, Veenstra R, Weigel B, Hirashima M, Munn D, et al.
Blood
. 2011 Mar;
117(17):4501-10.
PMID: 21385853
Tumor-associated immune suppression can lead to defective T cell-mediated antitumor immunity. Here, we identified a unique phenotype of exhausted T cells in mice with advanced acute myelogenous leukemia (AML). This...
16.
Zhou Q, Munger M, Highfill S, Tolar J, Weigel B, Riddle M, et al.
Blood
. 2010 Jun;
116(14):2484-93.
PMID: 20570856
Tumor-induced immune defects can weaken host immune response and permit tumor cell growth. In a systemic model of murine acute myeloid leukemia (AML), tumor progression resulted in increased regulatory T...
17.
Zhou Q, Bucher C, Munger M, Highfill S, Tolar J, Munn D, et al.
Blood
. 2009 Sep;
114(18):3793-802.
PMID: 19724059
Tumor-induced immune suppression can permit tumor cells to escape host immune resistance. To elucidate host factors contributing to the poor response of adoptively transferred tumor-reactive cytotoxic T lymphocytes (CTLs), we...